DeepThink PTB 2.02

DeepThink Health Precision Tumor Board™

Advancing medicine with precision intelligence™

The DeepThink Health Precision Tumor Board™ represents a significant advancement in the application of precision medicine through its innovative platform. This system adeptly captures and organizes extensive clinical and genomic datasets, leveraging advanced analytics and machine learning to facilitate precision medicine applications. In addition to the desktop version, the mobile app successfully integrates and processes cancer patients' molecular and genomic tumor reports, thereby enhancing the capabilities of both Molecular Tumor Board and Standard Tumor Board in interpreting complex data efficiently for oncologists who must make timely treatment decisions.

The key functionalities available to Tumor Board members include:

• Rapid access to FDA-approved therapies with predictive responses tailored to the patient’s specific tumor type and genetic characteristics.
• Streamlined selection of targeted therapies based on biomarker analysis or recommendations for improving molecular report interpretation.
• Insights into clinical trials previously screened in context for each patient case.
• Facilitation of collaboration among Molecular Tumor Board members to produce concise reports for treating oncologists efficiently.
• The capability to schedule and conduct virtual tumor board meetings.
• Compliance with HIPAA regulations ensuring that no private health information is stored or transmitted within the application.

About DeepThink Health

DeepThink Health has established itself as a leader in precision intelligence by developing a platform that organizes extensive clinical and genomic datasets. With vast experience in the Healthcare IT space, our team has a proven track record of success in partnering with healthcare providers, payers, and pharmacies. Our Precision Analytics and Precision Intelligence solutions have been effectively implemented at major Healthcare Integrated Delivery Networks (IDNs), where genomic, clinical, and outcome data have been thoroughly analyzed using DeepThink's Artificial Intelligence tools to advance precision medicine and foster groundbreaking discoveries.